<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66947">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01662739</url>
  </required_header>
  <id_info>
    <org_study_id>Donida-1</org_study_id>
    <nct_id>NCT01662739</nct_id>
  </id_info>
  <brief_title>Population-Based Stomach Cancer Registry</brief_title>
  <acronym>GCR</acronym>
  <official_title>Creation of a Population-Based Stomach Cancer Registry in the Cremona Province Area in Italy. Study of the Epidemiology, the Risk Factors and Clinical, Histological and Biomolecular Features of the Pathology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicina e Arte Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituti Ospitalieri di Cremona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale di Cremona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera di Crema</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Casa di Cura Figlie di San Camillo di Cremona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Casa di Cura San Camillo di Cremona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Casa di Cura Ancelle della Carit√† di Cremona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medicina e Arte Onlus</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric cancer remains one of the leading causes of cancer-related deaths worldwide. There
      is difference between different countries in the world in the incidence and outcome. Also
      Italy on its inside shows a variability between regions and Lombardy hold the most incidence
      and mortality Italian rate, with the province of Cremona as one of the leading area with its
      gastric cancer mortality rate. (http://www.aslcremona.it/html/atlante/introduzione.htm).
      Tumor specialized registry can be viewed as one of the main strategies for studying and
      monitoring the impact of an important cancer diagnosis. In addition the information obtained
      from it can be translated into preventive measures and health surveillance that might lead
      to a better control of this tumor in a province with a so high mortality rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Project purpose is to define the incidence of gastric cancer in the province of Cremona and
      the correlation with environmental, familiar, genetic and social factors; to adopt
      prevention strategies to reduce the impact of the disease and to create a gastric cancer
      bio-bank, including blood and tissue samples, for collaborative research projects regarding
      molecular and cellular aspects of gastric cancer.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Collection of life-style, familiar, clinical, histological and biomolecular data</measure>
    <time_frame>Five Years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collection of biological samples (blood and cancer tissue samples)</measure>
    <time_frame>Five Years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Analysis of epidemiology, risk factors, family history and unidentified susceptibility genes and proteins</measure>
    <time_frame>Five Years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Primary Stomach Carcinoma:</condition>
  <condition>Adenocarcinoma</condition>
  <condition>Papillary Adenocarcinoma</condition>
  <condition>Tubular Adenocarcinoma</condition>
  <condition>Mucinous Adenocarcinoma</condition>
  <condition>Signet-ring Cell Carcinoma</condition>
  <condition>Adenosquamous Carcinoma</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Small Cell Carcinoma</condition>
  <condition>Undifferentiated Carcinoma</condition>
  <condition>Other (Specify)</condition>
  <condition>Or Primary:</condition>
  <condition>Esophagogastric Junction Carcinoma</condition>
  <condition>Neuroendocrine Tumors</condition>
  <condition>GiST</condition>
  <condition>LNH</condition>
  <arm_group>
    <arm_group_label>Reisdent in Cremona</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <arm_group_label>Reisdent in Cremona</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and Cancer Tissue Sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  Primary Stomach Carcinoma (WHO Classification, 7th Ed.)

               -  Adenocarcinoma (Intestinal type; Diffuse type)

               -  Papillary adenocarcinoma

               -  Tubular adenocarcinoma

               -  Mucinous adenocarcinoma (&gt; 50% mucinous)

               -  Signet-ring cell carcinoma (&gt; 50% signet-ring cells)

               -  Adenosquamous carcinoma

               -  Squamous cell carcinoma

               -  Small cell carcinoma

               -  Undifferentiated carcinoma

               -  Other (specify) Or primary

               -  Esophagogastric junction carcinoma

               -  Neuroendocrine tumors

               -  GiST

               -  LNH

          -  Patients Cremona's province residence at diagnosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mentally competent and able to provide informed consent

        Exclusion Criteria:

          -  Not Resident in Cremona province at diagnosis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rodolfo Passalacqua, MD</last_name>
    <email>r.passalacqua@ospedale.cremona.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituti Ospitalieri di Cremona</name>
      <address>
        <city>Cremona</city>
        <zip>26100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodolfo Passalacqua, MD</last_name>
      <email>r.passalacqua@ospedale.cremona.it</email>
    </contact>
    <investigator>
      <last_name>Rodolfo Passalacqua, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>September 12, 2012</lastchanged_date>
  <firstreceived_date>August 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituti Ospitalieri di Cremona</investigator_affiliation>
    <investigator_full_name>Bianca Maria Donida, Ph.D</investigator_full_name>
    <investigator_title>Bianca Maria Donida</investigator_title>
  </responsible_party>
  <keyword>Population-Based Cancer Registry</keyword>
  <keyword>Stomach</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Risk Factor</keyword>
  <keyword>Biomolecular Features</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Adenocarcinoma, Papillary</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Adenocarcinoma, Mucinous</mesh_term>
    <mesh_term>Cystadenocarcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Small Cell Lung Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Small Cell</mesh_term>
    <mesh_term>Carcinoma, Adenosquamous</mesh_term>
    <mesh_term>Carcinoma, Signet Ring Cell</mesh_term>
    <mesh_term>Neuroendocrine Tumors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
